cancer

Biotech

Immunomedics halts late-stage clinical trial, confirming drug benefit for aggressive type of breast cancer

By Adam Feuerstein

Summit immunotherapy
First Opinion

Predicting immunotherapy success: We’ve mastered the foothills but the summit lies ahead

By Thomas Davis and Jessica Flechtner

MIT-Koch-Institute Madness
In the Lab

MIT’s Koch Institute wins STAT Madness with technology to see tiny ovarian tumors

By Elizabeth Cooney

John V. Oyler, CEO of BeiGene
Pharmalot

The tables are turned: Chinese regulator scolds a U.S. company for drug-manufacturing problems

By Ed Silverman

STAT SPOTLIGHT
Biotech

Startup Spotlight: Carisma Therapeutics wants to make a cell therapy that will work in solid tumors

By Kate Sheridan

Stock Market Down
Biotech

As the market craters, Keros Therapeutics files for an IPO

By Kate Sheridan

Melanie Wardell
Biotech

To quell unpredictable allergic reactions, an experimental drug takes aim at a genetic cause, not symptoms

By Damian Garde

Fusobacterium nucleatum micrograph
Biotech

Microbial signatures in the blood could offer new avenue for liquid biopsies to detect cancer

By Rebecca Robbins

China flags
Biotech

Global companies expand the reach of their cancer drugs in China

By Jonathan Chan

Biotech

Cancer biotech gets another new name (now it’s called Xilio) and more than $100 million

By Jonathan Saltzman — Boston Globe

Daniel O'Day
Biotech

CEO Daniel O’Day explains why Gilead paid $4.9 billion for Forty Seven

By Matthew Herper

Stark medication bottle
Pharmalot

FDA petitioned to recall batches of metformin diabetes pill over a possible carcinogen

By Ed Silverman

Todd Mercer clinical trials
Biotech

Turned away from five clinical trials, a cancer patient waits for one that will take him

By Rebecca Robbins, Damian Garde, and Adam Feuerstein

HPV infection
First Opinion

A single-dose HPV vaccine would have a big impact on cancer prevention

By Ronald A. DePinho

Cervical cancer cells
Biotech

Antigen-based metric could better predict which patients benefit from immunotherapy, study says

By Shafaq Zia

Maine Lobsters
Health

Claws of health? Lobster blood could play role in new drugs

By Associated Press

ProstateCancerCell
Biotech

With new combination drug data, Exelixis takes another shot at prostate cancer treatment

By Adam Feuerstein

Dna test infographic
First Opinion

I was fortunate to get post-23andMe genetic counseling. Everyone should have that option

By Dorothy Pomerantz

Jeff Bluestone
Biotech

Jeffrey Bluestone steps down as Parker Institute president to develop cell therapies for autoimmune diseases

By Matthew Herper

Biotech

European regulators could take a harder line on the review of an Agios blood cancer drug

By Adam Feuerstein

doctor-entrepreneur’s guide
First Opinion

A doctor-entrepreneur’s guide to socially responsible capitalism

By Thomas Grogan

Novartis International pharmaceutical
Pharmalot

U.S. officials will let Novartis pay expenses for some Kymriah patients who must travel for treatment

By Ed Silverman

European Medicines Agency
Pharmalot

Most innovative cancer drugs take too long to reach patients in the U.K.

By Ed Silverman

Big data concept illustration
Exclusive

Medical data startup Syapse cuts 10% of workforce as it prioritizes data analytics and insights

By Rebecca Robbins

Roche headquarters
Pharmalot

Roche is fined by Romania for thwarting competition to its cancer medicines

By Ed Silverman

In the Lab

Could a drug for arthritis in dogs also fight cancer in people?

By Jonathan Saltzman — Boston Globe

ASH19 Lymphoma
In the Lab

Tweaking how CAR-T therapy kills tumors could stop a dangerous side effect, study finds

By Sharon Begley

Play
The Readout LOUD

Listen: A J.P. Morgan recap, a plan to bust pharma monopolies, and a website for cancer patients

By Rebecca Robbins, Damian Garde, and Adam Feuerstein

stem cells from bone marrow
Health

Previously unseen mutations in stem cells of young donors can be passed to recipients, study finds

By Andrew Joseph

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy